Detecting sepsis in the ventilated patient
16 Jan 2025
In this sixth session presented at the 2024 World Sepsis Congress Spotlight: Unmet Need in Sepsis Diagnosis and Therapy, the relationship between acute respiratory distress syndrome (ARDS) and sepsis is explored. Find out more about ventilator support in cases of sepsis in low-middle income countries, how biomarkers can be used in ARDS and sepsis, phenotypes and genetics in ARDS and sepsis, and the new global definition of ARDS.
Time stamps for easy viewing:
00:00:00 Introduction
00:01:17 Michael Matthay, University of California, San Franscisco, USA – New Global Definition of Acute Respiratory Distress Syndrome (ARDS)
00:16:42 Lieuwe Bos, Amsterdam UMC – Alveolar Inflammation in ARDS
00:33:18 Lorraine Ware, Vanderbilt University, USA – Biomarkers in ARDS and Sepsis
00:49:22 Carmen Barbas, University of São Paulo, Brazil – Unraveling the Enigma of Genetics and Phenotypes in Sepsis and ARDS
01:02:26 Pedro Povoa, University of Lisboa, Portugal – Diagnosis of Ventilator-Associated Pneumonia
01:20:59 Marcus Schultz, Mahidol University, Thailand – Ventilator Support and Sepsis in Low-Middle Income Countries
About the company
Global Sepsis Alliance
The Global Sepsis Alliance (GSA) is a non-profit charity organization with the mission to provide global leadership to reduce the worldwide burden of sepsis. The GSA is the initiator of World Sepsis Day on September 13 and World Sepsis Congress, a series of free online congresses bringing knowledge about sepsis to all parts of the world, among other initiatives.
The GSA works closely with its over 120 member organizations from all over the world – patient advocacy groups, professional societies, healthcare authorities, and governments – to implement changes on how sepsis is prioritized, diagnosed, and treated all around the world, as laid out in the WHO Resolution on Sepsis.
